Should deep venous thrombosis prophylaxis be used in fast-track hip and knee replacement?

Acta Orthopaedica

Volumn 83, Issue 2, 2012, Pages 105-106

  Kjærsgaard Andersen, Per ^a,c   Kehlet, Henrik ^b,c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Rigshospitalet   (Denmark)

^c H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; DEEP VEIN THROMBOSIS; EDITORIAL; HIP ARTHROPLASTY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; PHLEBOGRAPHY; PRACTICE GUIDELINE; THROMBOSIS PREVENTION; TOTAL KNEE REPLACEMENT;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; HUMANS; IMMOBILIZATION; LENGTH OF STAY; TIME FACTORS; VENOUS THROMBOSIS;

EID: 84860234612     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453674.2012.672094     Document Type: Editorial

References (20)

1. Chandrasekaran S, Ariaretnam S K, Tsung J, Dickison D. Early mobilization after total knee replacement reduces the incidence of deep venous thrombosis. ANZ J Surg 2009; 79 (7-8): 526-9.
2. Davies R G, Rayment R. Primum non nocere - NICE guidelines on venous thromboembolism. Anaesthesia 2010; 65 (8): 774-8.
3. Eriksson B I, Borris L C, Friedman R J, Haas S, Huisman M V, Kakkar A K, Bandel T J, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008; 358 (26): 2765-75.
4. Geerts W H, Bergqvist D, Pineo G F, Heit J A, Samama C M, Lassen M R, Colwell C W. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).Chest (6 Suppl) 2008; 133: 381S-453S.
5. Husted H, Otte K S, Kristensen B B, Orsnes T, Wong C, Kehlet H. Low risk of thromboembolic complications after fast-track hip and knee arthroplasty. Acta Orthop 2010; 81 (5): 599-605.
6. Husted H, Lunn T H, Troelsen A, Gaarn-Larsen L, Kristensen B B, Kehlet H. Why still in hospital after fast-track hip and knee arthroplasty? Acta Orthop 2011; 82 (6): 679-84.
7. Jameson S S, Bottle A, Malviya A, Muller S D, Reed M R. The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb. J Bone Joint Surg (Br) 2010; 92 (1): 123-9.
8. Kakkar A K, Rushton-Smith S. Venous thromboembolism pharmacologic prophylaxis after major surgery-are we doing well or not well enough? Ann Surg 2011; 253 (2): 221-2.
9. Kakkar A K, Brenner B, Dahl O E, Eriksson B I, Mouret P, Muntz J, Soglian A G, Pap A F, Misselwitz F, Haas S. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008; 372 (9632): 31-9.
10. Kerr D R, Kohan L. Local infiltration analgesia: a technique for the control of acute postoperative pain following knee and hip surgery: a case study of 325 patients. Acta Orthop 2008; 79 (2): 174-83.
11. Lassen M R, Gallus A, Raskob G E, Pineo G, Chen D, Ramirez L M. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med 2010a; 363 (26): 2487-98.
12. Lassen M R, Raskob G E, Gallus A, Pineo G, Chen D, Hornick P. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet 2010b; 375 (9717): 807-15.
13. Lee Y-K, Chung C Y, Koo K-H, Lee K M, Ji H-M, Park M S. Conflict of Interest in the Assessment of Thromboprophylaxis After Total Joint Arthroplasty: A Systematic Review. J Bone Joint Surg (Am) 2012; 94 (1): 27-33.
14. Malviya A, Martin K, Harper I, Muller S D, Emmerson K P, Partington P F, Reed M R. Enhanced recovery program for hip and knee replacement reduces death rate. Acta Orthop 2011; 82 (5): 577-81.
15. McDonald D A, Siegmeth R, Deakin A H, Kinninmonth A W, Scott N B. An enhanced recovery programme for primary total knee arthroplasty in the United Kingdom-follow up at one year. Knee 2011; doi: 10.1016/j. knee.2011.07.012
16. Polk H C, Jr., Qadan M. Prevention of venous thromboembolism after elective surgery is better influenced by judgement than by protocols. Br J Surg 2010; 97 (9): 1315-7.
17. Poultsides L A, Gonzalez Della Valle A, Memtsoudis S G, Ma Y, Roberts T, Sharrock N, Salvati E. Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens. J Bone Joint Surg (Br) 2012; 94 (1): 113-21.
18. Qadan M, Polk H C, Jr., Hohmann S F, Fry D E. A reassessment of needs and practice patterns in pharmacologic prophylaxis of venous thromboembolism following elective major surgery. Ann Surg 2011; 253 (2): 215-20.
19. Treasure T, Chong L Y, Sharpin C, Wonderling D, Head K, Hill J. Developing guidelines for venous thromboembolism for The National Institute for Clinical Excellence: involvement of the orthopaedic surgical panel. J Bone Joint Surg (Br) 2010; 92 (5): 611-6.
20. Turpie A G, Lassen M R, Davidson B L, Bauer K A, Gent M, Kwong L M, Cushner F D, Lotke P A, Berkowitz S D, Bandel T J, Benson A, Misselwitz F, Fisher W D. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 2009; 373 (9676): 1673-80.